Literature DB >> 34040450

Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia.

Setegn Bayabil1, Awoke Seyoum2.   

Abstract

BACKGROUND: Globally, for individuals infected with HIV, the presence of other infections including TB tends to increase the rate of HIV replication. Of the 8.8 million TB cases worldwide, an estimated 1.1 million (13%) were found to be co-infected with HIV. This research was conducted with the objective to identify potential predictors for the status of TB and CD4 cell count under PLWHIV at Felege Hiwot Specialized Hospital, North-west Ethiopia.
METHODS: A retrospective repeated measurement was taken from a sample of 226 HIV patients. Separate and joint models were conducted for data analysis of CD4 cell count and TB status of people living with HIV.
RESULTS: The descriptive statistics indicated that among the HIV patients receiving HAART, 26.6% had additional TB. AIDS clinical stage, weight, and hemoglobin level had a significant positive association with CD4 cell count, but a negative association with TB status. Weight and CD4 cell count have a negative relationship with the event of HIV/TB co-infection. Hence, the expected number of CD4 cell count of HIV patients who were co-infected with TB was decreased by 2.34 as compared to people living with HIV without TB. As visiting times of patients to hospitals for treatment increased by one unit, the odds of being co-infected with TB was decreased by 0.05, and the expected number of CD4 cell count was increased by 0.2. As patients' age increased by one year, the expected number of CD4 cell count was decreased by 0.025 cells per/mm3.
CONCLUSION: Having lower CD4 cell count, lower weight, late WHO clinical stage, being non-adherent, having opportunistic infection, having lower hemoglobin, being ambulatory and bedridden were associated with a higher risk of co-infection of HIV/TB and were indicators of progression of the disease.
© 2021 Bayabil and Seyoum.

Entities:  

Keywords:  CD4 cell; HAART; TB status; joint model; separate model

Year:  2021        PMID: 34040450      PMCID: PMC8140895          DOI: 10.2147/HIV.S307069

Source DB:  PubMed          Journal:  HIV AIDS (Auckl)        ISSN: 1179-1373


  17 in total

1.  HIV and tuberculosis coinfection in the southern region of Ethiopia: a prospective epidemiological study.

Authors:  Mohammed Ahmed Yassin; Luelseged Takele; Sahlemariam Gebresenbet; Emebet Girma; Meskele Lera; Ersido Lendebo; Luis E Cuevas
Journal:  Scand J Infect Dis       Date:  2004

2.  The impact of adherence on CD4 cell count responses among HIV-infected patients.

Authors:  Evan Wood; Robert S Hogg; Benita Yip; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2004-03-01       Impact factor: 3.731

Review 3.  Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis.

Authors:  P I Fujiwara; P Clevenbergh; R A Dlodlo
Journal:  Int J Tuberc Lung Dis       Date:  2005-09       Impact factor: 2.373

4.  Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia.

Authors:  Max Katubulushi; Isaac Zulu; Felistah Yavwa; Paul Kelly
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

Review 5.  HIV-TB co-infection: epidemiology, diagnosis & management.

Authors:  S K Sharma; Alladi Mohan; Tamilarasu Kadhiravan
Journal:  Indian J Med Res       Date:  2005-04       Impact factor: 2.375

6.  Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.

Authors:  William Worodria; Marguerite Massinga-Loembe; Doreen Mazakpwe; Kenneth Luzinda; Joris Menten; Frank Van Leth; Harriet Mayanja-Kizza; Luc Kestens; Roy D Mugerwa; Peter Reiss; Robert Colebunders
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

Review 7.  Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

Authors:  G Sotgiu; G Ferrara; A Matteelli; M D Richardson; R Centis; S Ruesch-Gerdes; O Toungoussova; J-P Zellweger; A Spanevello; D Cirillo; C Lange; G B Migliori
Journal:  Eur Respir J       Date:  2009-02-27       Impact factor: 16.671

8.  Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet HIV       Date:  2016-07-19       Impact factor: 12.767

9.  The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Authors:  Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

Review 10.  HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide.

Authors:  Maria Theresa Montales; Arun Chaudhury; Alexandria Beebe; Sowmya Patil; Naveen Patil
Journal:  Front Public Health       Date:  2015-12-23
View more
  2 in total

1.  Risk Factors for the Development of Tuberculosis Among HIV-Positive Adults Under Highly Active Antiretroviral Therapy at Government Hospitals in Amhara Region, Ethiopia.

Authors:  Awoke Seyoum Tegegne; Molalign Tarekegn Minwagaw
Journal:  Int J Gen Med       Date:  2022-03-15

2.  Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia.

Authors:  Demeke Geremew; Habtamu Geremew; Mebratu Tamir; Mohammed Adem; Birhanemeskel Tegene; Biruk Bayleyegn
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.